Expression of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma cells is downregulated upon inhibition of BRAF
Karolina Uranowska(Karl Landsteiner University of Health Sciences), Christine Häfner(Karl Landsteiner University of Health Sciences)
Cited by 17
Related Papers
<scp>EAACI</scp>Molecular Allergology User's Guide 2.0
|Pediatric Allergy and Immunology|2023|259
Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia
|International Journal of Oncology|2015|16